产品[
HB-10744 SH-3 鼠杂交瘤细胞
]资料
如果您对该产品感兴趣的话,可以
产品名称:
HB-10744 SH-3 鼠杂交瘤细胞
产品型号:
HB-10744
产品厂商:
美国标准生物品收藏中心(ATCC)
产品文档:
无相关文档
简单介绍
HB-10744 SH-3 鼠杂交瘤细胞,ATCC 细胞|细胞系|细胞株|肿瘤细胞株|细胞|贴壁细胞|悬浮细胞|;细胞库管理规范,提供的细胞株背景清楚,提供参考文献和Z优培养条件
HB-10744 SH-3 鼠杂交瘤细胞
的详细介绍
HB-10744 SH-3 鼠杂交瘤细胞
|
HB-10744™
|
|
$399.00
|
|
SH3
|
|
Osiris Therapeutics, Inc.
|
|
IgG2b
|
Biosafety Level:
|
1
|
|
frozen
|
Medium & Serum:
|
See Propagation
|
|
suspension
|
|
Mus musculus (B cell); Mus musculus (myeloma) (mouse (B cell); mouse (myeloma))
|
|
lymphoblast
|
|
Cell Type: hybridoma: B lymphocyte;
|
|
immunoglobulin; monoclonal antibody; against human mesenchymal stem cells
|
|
In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
|
|
|
Yes
|
|
ATCC complete growth medium: Modified Dulbecco's medium, 85%; fetal bovine serum, 15%
Temperature: 37.0°C
|
|
Medium Renewal: Every 2 to 3 days
Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 2 X 10 exp5 and 1 X 10 exp6 cells/ml.
|
|
culture medium 95%; DMSO, 5%
|
|
recommended serum:ATCC 30-2020
Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 46-X
|
|
22086: Caplan AI, Haynesworth SE. Human mesenchymal stem cells. US Patent 5,486,359 dated Jan 23 1996
49752: Haynesworth SE, et al. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 13: 69-80, 1992. PubMed: 1316137
|
|
ATCC® Number: HB-10744™ Price: $399.00
Designations: SH3
Depositors: Osiris Therapeutics, Inc.
Isotype: IgG2b
Biosafety Level: 1
Shipped: frozen
Medium & Serum: See Propagation
Growth Properties: suspension
Organism: Mus musculus (B cell); Mus musculus (myeloma) (mouse (B cell); mouse (myeloma))
Morphology: lymphoblast
Source: Cell Type: hybridoma: B lymphocyte;
Cellular Products: immunoglobulin; monoclonal antibody; against human mesenchymal stem cells
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Tumorigenic: Yes
Comments: Animals were immunized with human mesenchymal stem cells.
Spleen cells were fused with Sp2/0-Ag14 mouse myeloma cells.
The antibody reacts with mesenchymal stem cells from bone marrow and some tissues of mesenchymal origin.
Propagation: ATCC complete growth medium: Modified Dulbecco's medium, 85%; fetal bovine serum, 15%
Temperature: 37.0°C
Subculturing: Medium Renewal: Every 2 to 3 days
Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 2 X 10 exp5 and 1 X 10 exp6 cells/ml.
Preservation: culture medium 95%; DMSO, 5%
Related Products: recommended serum:ATCC 30-2020
Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 46-X
References: 22086: Caplan AI, Haynesworth SE. Human mesenchymal stem cells. US Patent 5,486,359 dated Jan 23 1996
49752: Haynesworth SE, et al. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 13: 69-80, 1992. PubMed: 1316137